Table of Contents
Chapter 1. Global Retinal Vein Occlusion Treatment Market Executive Summary
1.1. Global Retinal Vein Occlusion Treatment Market Size & Forecast (2022- 2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Disease Type
1.3.2. By Treatment
1.3.3. By End-user
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Retinal Vein Occlusion Treatment Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Retinal Vein Occlusion Treatment Market Dynamics
3.1. Market Drivers
3.1.1. Aging Population
3.1.2. Advancements in Therapeutic Technologies
3.1.3. Rising Awareness and Early Diagnosis
3.2. Market Challenges
3.2.1. High Treatment Costs
3.3. Market Opportunities
3.3.1. Emerging Markets
3.3.2. Biologics and Personalized Medicine
Chapter 4. Global Retinal Vein Occlusion Treatment Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Retinal Vein Occlusion Treatment Market Size & Forecasts by Disease Type 2024-2032
5.1. Segment Dashboard
5.2. Global Retinal Vein Occlusion Treatment Market: Disease Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Central Retinal Vein Occlusion (CRVO)
5.2.2. Branch Retinal Vein Occlusion (BRVO)
Chapter 6. Global Retinal Vein Occlusion Treatment Market Size & Forecasts by Treatment 2024-2032
6.1. Segment Dashboard
6.2. Global Retinal Vein Occlusion Treatment Market: Treatment Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Anti-vascular Endothelial Growth Factor (Anti-VEGF)
6.2.2. Corticosteroid Drugs
6.2.3. Others
Chapter 7. Global Retinal Vein Occlusion Treatment Market Size & Forecasts by End-user 2024-2032
7.1. Segment Dashboard
7.2. Global Retinal Vein Occlusion Treatment Market: End-user Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Hospital & Clinics
7.2.2. Retail Pharmacy
7.2.3. Others
Chapter 8. Global Retinal Vein Occlusion Treatment Market Size & Forecasts by Region 2024-2032
8.1. North America Retinal Vein Occlusion Treatment Market
8.1.1. U.S. Retinal Vein Occlusion Treatment Market
8.1.1.1. Disease Type breakdown size & forecasts, 2024-2032
8.1.1.2. Treatment breakdown size & forecasts, 2024-2032
8.1.1.3. End-user breakdown size & forecasts, 2024-2032
8.1.2. Canada Retinal Vein Occlusion Treatment Market
8.2. Europe Retinal Vein Occlusion Treatment Market
8.2.1. U.K. Retinal Vein Occlusion Treatment Market
8.2.2. Germany Retinal Vein Occlusion Treatment Market
8.2.3. France Retinal Vein Occlusion Treatment Market
8.2.4. Spain Retinal Vein Occlusion Treatment Market
8.2.5. Italy Retinal Vein Occlusion Treatment Market
8.2.6. Rest of Europe Retinal Vein Occlusion Treatment Market
8.3. Asia-Pacific Retinal Vein Occlusion Treatment Market
8.3.1. China Retinal Vein Occlusion Treatment Market
8.3.2. India Retinal Vein Occlusion Treatment Market
8.3.3. Japan Retinal Vein Occlusion Treatment Market
8.3.4. Australia Retinal Vein Occlusion Treatment Market
8.3.5. South Korea Retinal Vein Occlusion Treatment Market
8.3.6. Rest of Asia Pacific Retinal Vein Occlusion Treatment Market
8.4. Latin America Retinal Vein Occlusion Treatment Market
8.4.1. Brazil Retinal Vein Occlusion Treatment Market
8.4.2. Mexico Retinal Vein Occlusion Treatment Market
8.4.3. Rest of Latin America Retinal Vein Occlusion Treatment Market
8.5. Middle East & Africa Retinal Vein Occlusion Treatment Market
8.5.1. Saudi Arabia Retinal Vein Occlusion Treatment Market
8.5.2. South Africa Retinal Vein Occlusion Treatment Market
8.5.3. Rest of Middle East & Africa Retinal Vein Occlusion Treatment Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. AbbVie Inc.
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. F. Hoffmann-La Roche Ltd.
9.3.3. Regeneron Pharmaceuticals Inc.
9.3.4. Aerie Pharmaceuticals Inc.
9.3.5. Pfizer Inc.
9.3.6. Taiwan Liposome Company, Ltd.
9.3.7. CalciMedica Inc.
9.3.8. Kodiak Sciences Inc.
9.3.9. Chugai Pharmaceutical Co., Ltd.
9.3.10. Outlook Therapeutics, Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes